Vitamin K-inhibiting anticoagulants, especially warfarin, have become standard treatment for reducing the incidence of strokes and systemic emboli in patients with nonvalvular atrial fibrillation ...

Data from a Japanese registry may be useful for characterizing frailty among older patients with nonvalvular atrial fibrillation (NVAF), possibly opening the door to better treatment decisions and ...

Atrial fibrillation (AF) is the most common cardiac ... aspirin in patients unsuitable for warfarin in stroke prevention in nonvalvular AF. There is a need to reconsider the benefits of using ...

Atrial fibrillation (AFib) is an irregular and often rapid heart rhythm. The terms “controlled AFib” and “uncontrolled AFib” describe whether treatment strategies are effectively managing ...

If you have AFib, treating it cuts your risk of having a stroke. But it can be costly, even if you have insurance. AFib doesn’t so much have types as it has durations. Doctors classify it by how ...

It can also be taken to reduce the risk of stroke for people who experience nonvalvular atrial fibrillation, or an irregular ...

Individuals who intend to improve their cardiovascular health often use Magnesium supplements, particularly those dealing with atrial fibrillation (afib). Afib is a condition marked by an ...

It beats around 60-100 times per minute when you're resting. If you have atrial fibrillation, though, your heart can beat out of rhythm, too fast, or too slow. Untreated AFib might also make you ...

Sales of Eliquis were up 9%, driven by continued oral anti-coagulant adoption and market-share gains in the nonvalvular atrial fibrillation indication in the U.S. and certain markets in Europe.

Sales of Eliquis were up 9%, driven by continued oral anti-coagulant adoption and market-share gains in the nonvalvular ...